Virtual Tools for Promoting Diversity in Pharma and Clinical Trials
It is no secret that Pharma (still) has a major diversity problem. Not only on their own senior leadership teams but also in their clinical…
Pharma
Growing Smart Capabilities for a Data-centric Future
Most life sciences Regulatory teams still think and work in terms of documents, paragraphs and sentences when putting together collateral for marketing authorisation and variations…
From Apothecaries to Apps: Reflecting on 300 years of Pharmacy Innovation
The last 300 years have seen phenomenal evolution in our understanding of, and approach to managing human health and wellbeing. It’s fair to say that…
Pharma for Women: How Should Pharma Companies Respond to the UK’s Women’s Health Strategy
Released this July, the UK Government’s Women’s Health Strategy aimed to address a very complex problem – gender inequality across the healthcare sector. Whilst the…
Modernisation of Clinical Trials Amidst the Pandemic
Globally, researchers have long since been working on various aspects of medicine and clinical trials are a core part of developing medicinal and health development…
Pathology and Technology; Developing Together
Richard Craven, CliniSys UK and Ireland Managing Director, considers some of the big developments in pathology and how technology will help laboratories to confront current…
Cross-functional Innovation must Drive Pharma Commercialisation
Successful pharma companies are adapting commercialisation strategies to align with transformation in healthcare delivery. Vintura’s Richard Ogborne and Chris Reynolds provide practical guidance as to…
Partnering with Patients and Caregivers in Clinical Research
One definition of patient-centricity is “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best…
When and Where to use Virtual Engagement for Face-to-face Life Science Congresses
COVID-19 disrupted and redefined the structure of life science congresses – large annual meetings where HCPs and drug and device developers come together to exchange…
Getting Data in Order for a Data-driven Future
As data becomes more important than documents when it comes to regulatory submissions and operational decision-making, there is a renewed focus on data quality. Amplexor’s…